메뉴 건너뛰기




Volumn 10, Issue 6, 2012, Pages 660-662

Why is it taking so long to develop clinically competitive stem cell therapies for CNS disorders?

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CENTRAL NERVOUS SYSTEM DISEASE; CORPUS STRIATUM; COST EFFECTIVENESS ANALYSIS; DENERVATION; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EMBRYONIC STEM CELL; HUMAN; HUNTINGTON CHOREA; MEDICAL RESEARCH; MOTONEURON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PYRAMIDAL TRACT; RISK BENEFIT ANALYSIS; SHORT SURVEY; STEM CELL TRANSPLANTATION; SUBSTANTIA NIGRA; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 84862524308     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2012.04.004     Document Type: Note
Times cited : (15)

References (9)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.